Cambridge, UK, June 22, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that it unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium in Tours, France, 22-23 June 2023.
ATLX-1088 is a potential first-in-class human antibody targeting CD33, a cell surface protein which is thought to have a key role in Alzheimer’s disease. Studies have found that higher expression of CD33 is associated with more advanced…
- Data presented at the American Diabetes Association 83rd Scientific Sessions
- AT247 delivers significantly accelerated insulin absorption and early exposure (PK profile) compared with NovoLog® and Fiasp®
- Further supports potential to enable more effective disease management for people with Type I diabetes via fully automated closed loop insulin pump delivery (artificial pancreas)
Cambridge, UK, 26 June 2023. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that positive results from its second Phase…
VOTE NOW
We are delighted to announce the following companies as finalists in our BioNewsRound Award 2023.
Astex - Astex hails trials success of superdrug that saves lives and cuts recurrence risk for thousands of breast cancer patients
AstraZeneca - AstraZeneca and Quell Therapeutics line up $2.85bn alliance
Macomics - Macomics and Ono Pharmaceutical partner to discover and develop macrophage-targeting antibody therapy
PharmEnable - PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and…
Discover how four seperate developments are making their mark in history at Norwich Research Park following a recent announcement from Anglia Innovation Partnership CEO, Roz Bird, at the 'Innovation in the East of England' event. Read more...
The news article shares insights into:
The Genetic Technology (Precision Breeding) Bill
The results of a study 'Life Science: beyond Human Health' launched by the Government Office for Science.
£164m of investment announced by the BBSRC.
A major investment from UKRI in plant and microbial research hub, totalling £317m over ten years…
Check out the latest updates on LBIC's expansion, investment, seaweed and virtual tenancy offers in the latest LBIC Newsletter: https://www.lbic.com/lbic-newsletter
During this episode of LifeArc's MND Translational Challenge podcast, titled 'Shaped by Patients. Guided by Experts: How we ensure patient voices are heard...', Rob Smith meets with Jane Hayley MBE, Director of Research, MND Scotland, Jessica Lee, Director of Research from My Name'5 Doddie, Paul Wicks a neuropsychologist who is overseeing the creation of LifeArc's MND Patient Insights Group and Dr Paul Wright who leads the LifeArc MND Translational Challenge.
They discuss why it is so important to include patients in medical research from scoping, inception through to governance and…
Bruntwood Scitech and three UK-based companies at the forefront of data-driven science innovation have published a white paper on 'The Ride of Tech Bio: Powering life science innovation'.
Download the report now and discover how tech bio is advancing life science organisations, sector growth in recent years and why the UK is a well-positioned hub for tech bio going forward.
Read the latest The Meeting Place newsletter here!
Keep updated with forthcoming One Nucleus events as well as external events where members can access discounts to attend.
Key executive appointment supports strategic operational delivery of the Company’s product and partnership programs
London, UK, 20 June 2023: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, today announced that it has appointed Kate Woolland as Chief Operating Officer. Kate joins CEO, Dr. Hakim Yadi PhD OBE, on the executive team to guide organizational and operational delivery of the Company’s lead programs, products and commercial partnerships.…
Award-winning digital marketing agency Sookio marks 15th anniversary with a fresh strategic offering and launch of innovative work experience initiatives.
Founded in 2008 by Ely businesswoman Sue Keogh, the company’s ethos is to Untangle your thinking – helping ambitious and transformative organisations to communicate their ideas to the world through brilliant digital strategy, content, and training.
Sue comments:“We’re so proud of the work we’ve done for clients including the NHS, University of Cambridge, Huntingdonshire and South Cambs District Councils, the BBC, and Alzheimer’s…